The dosage flexibility row says compounded preparations allow customizable strengths that a provider can fine-tune, while branded products come as fixed-dose pens or vials
(28) GLP-1 Agonists and Surgical Outcomes Pre-Clinical Studies Liu et al
Six of them, BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, earned favorable committee votes
New developments include orally administered GLP1RA, unimolecular glucagon receptor (GCGR)-GLP1R coagonists like survodutide, and GCGR- Gastric Inhibitory Polypeptide Receptor (GIPR)-GLP1R triagonists like retatrutide
However, each additional compound adds variables
Clinical studies several conducted or funded by parties with commercial interest report improvements in skin firmness, density, fine lines, and clarity, alongside faster wound healing (roughly 30% faster epithelialization in some reports)